|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.824
|
|
|
|
relaxation of smooth muscle
|
GO:0044557 |
8 |
0.795
|
|
|
|
negative regulation of peptidyl serine phosphorylation
|
GO:0033137 |
10 |
0.678
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.674
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.563
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.544
|
Fly |
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.544
|
|
|
|
relaxation of vascular smooth muscle
|
GO:0060087 |
7 |
0.543
|
|
|
|
positive regulation of cell proliferation involved in heart valve morphogenesis
|
GO:0003251 |
1 |
0.523
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.502
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.500
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.469
|
|
|
|
trunk segmentation
|
GO:0035290 |
4 |
0.454
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.425
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.418
|
|
|
|
germline cell cycle switching mitotic to meiotic cell cycle
|
GO:0051729 |
1 |
0.416
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.357
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.348
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.347
|
Fly |
|
|
response to sterol
|
GO:0036314 |
4 |
0.339
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.326
|
|
|
|
negative regulation of muscle contraction
|
GO:0045932 |
12 |
0.325
|
|
|
|
positive regulation of synapse assembly
|
GO:0051965 |
18 |
0.324
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.320
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.319
|
|
|
|
nephrogenic mesenchyme morphogenesis
|
GO:0072134 |
2 |
0.296
|
|
|
|
negative regulation of peptidyl threonine phosphorylation
|
GO:0010801 |
6 |
0.296
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.289
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.279
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.274
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.258
|
|
|
|
cell proliferation involved in heart valve morphogenesis
|
GO:0003249 |
1 |
0.256
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.252
|
|
|
|
kidney mesenchyme morphogenesis
|
GO:0072131 |
4 |
0.249
|
|
|
|
brainstem development
|
GO:0003360 |
3 |
0.231
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.231
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.221
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.193
|
|
|
|
germ line stem cell division
|
GO:0042078 |
2 |
0.192
|
|
|
|
metanephric mesenchyme morphogenesis
|
GO:0072133 |
4 |
0.191
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.183
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.173
|
|
|
|
endothelial cell activation
|
GO:0042118 |
1 |
0.173
|
|
|
|
regulation of smad protein import into nucleus
|
GO:0060390 |
3 |
0.165
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.164
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.158
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.158
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.155
|
|
|
|
regulation of adrenergic receptor signaling pathway
|
GO:0071877 |
4 |
0.152
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.150
|
|
|
|
mesendoderm development
|
GO:0048382 |
3 |
0.147
|
|
|
|
smad protein complex assembly
|
GO:0007183 |
1 |
0.142
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.136
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.135
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.134
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.131
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.128
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.124
|
|
|
|
nephrogenic mesenchyme development
|
GO:0072076 |
3 |
0.123
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.122
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.118
|
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
2 |
0.117
|
|
|
|
endocardial cushion formation
|
GO:0003272 |
13 |
0.117
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.115
|
|
|
|
tolerance induction to self antigen
|
GO:0002513 |
4 |
0.114
|
|
|
|
cell cycle switching mitotic to meiotic cell cycle
|
GO:0051728 |
1 |
0.113
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.111
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.110
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.108
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.108
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.107
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.106
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.105
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.105
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.103
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.101
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.099
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.099
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.098
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.095
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.090
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.089
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.089
|
|
|
|
positive regulation of smad protein import into nucleus
|
GO:0060391 |
2 |
0.088
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.087
|
|
|
|
negative regulation of insulin secretion
|
GO:0046676 |
14 |
0.087
|
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.087
|
|
|
|
regulation of cell proliferation involved in heart valve morphogenesis
|
GO:0003250 |
1 |
0.087
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.086
|
Fly |
|
|
peptidyl threonine modification
|
GO:0018210 |
31 |
0.086
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.086
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.085
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.085
|
Human |
|
|
negative regulation of serotonin uptake
|
GO:0051612 |
2 |
0.084
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.084
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.083
|
|
|
|
regulation of b cell tolerance induction
|
GO:0002661 |
2 |
0.083
|
|
|
|
positive regulation of b cell tolerance induction
|
GO:0002663 |
2 |
0.083
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.083
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.080
|
Human |
|
|
positive regulation of transcription from rna polymerase ii promoter involved in cellular response to chemical stimulus
|
GO:1901522 |
7 |
0.080
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.077
|
|
|
|
negative regulation of osteoblast proliferation
|
GO:0033689 |
4 |
0.077
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.076
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.076
|
|
|
|
regulation of osteoblast proliferation
|
GO:0033688 |
15 |
0.075
|
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
25 |
0.075
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
34 |
0.075
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.075
|
|
|
|
negative regulation of peptide hormone secretion
|
GO:0090278 |
16 |
0.074
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.073
|
Fly |
|
|
inflammatory response
|
GO:0006954 |
244 |
0.073
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.072
|
|
|
|
regulation of cardiac muscle contraction
|
GO:0055117 |
21 |
0.072
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.072
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.072
|
|
|
|
cgmp metabolic process
|
GO:0046068 |
20 |
0.071
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.071
|
|
|
|
drug metabolic process
|
GO:0017144 |
4 |
0.071
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.070
|
|
|
|
pathway restricted smad protein phosphorylation
|
GO:0060389 |
10 |
0.070
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.070
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.069
|
Fly |
|
|
response to growth factor
|
GO:0070848 |
198 |
0.069
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.069
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.068
|
|
|
|
response to cholesterol
|
GO:0070723 |
4 |
0.068
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.066
|
|
|
|
peptidyl threonine phosphorylation
|
GO:0018107 |
31 |
0.066
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.066
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.066
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.065
|
|
|
|
cell cell signaling involved in cell fate commitment
|
GO:0045168 |
35 |
0.065
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.064
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.063
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.062
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.061
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.060
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.060
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.060
|
Human |
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.059
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.059
|
Human |
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
43 |
0.059
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.058
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.058
|
|
|
|
lateral mesodermal cell differentiation
|
GO:0048371 |
3 |
0.058
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
34 |
0.057
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.057
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.057
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.057
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.056
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.056
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.055
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.055
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.054
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.054
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.054
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.053
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.053
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.053
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.053
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.053
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.053
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.052
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.051
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.051
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.051
|
Human |
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.050
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.050
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.050
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.050
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.050
|
|
|
|
foregut morphogenesis
|
GO:0007440 |
12 |
0.049
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.049
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.049
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.049
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.049
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.049
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.049
|
|
|
|
exogenous drug catabolic process
|
GO:0042738 |
1 |
0.049
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.049
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.049
|
|
|
|
osteoblast fate commitment
|
GO:0002051 |
4 |
0.048
|
|
|
|
regulation of tolerance induction
|
GO:0002643 |
10 |
0.048
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.048
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.048
|
|
|
|
cyclic nucleotide mediated signaling
|
GO:0019935 |
18 |
0.047
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.047
|
Human |
|
|
positive regulation of bmp signaling pathway
|
GO:0030513 |
23 |
0.047
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.047
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.047
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.046
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.046
|
|
|
|
chondrocyte hypertrophy
|
GO:0003415 |
4 |
0.046
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.045
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.045
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.045
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.045
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.045
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.045
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.045
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.045
|
Human |
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.044
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.044
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.044
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.044
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.044
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.044
|
|
|
|
negative regulation of endothelial cell differentiation
|
GO:0045602 |
2 |
0.044
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.043
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.043
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.043
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.043
|
|
|
|
cgmp mediated signaling
|
GO:0019934 |
3 |
0.043
|
|
|
|
heart formation
|
GO:0060914 |
16 |
0.042
|
|
|
|
endocardial cushion morphogenesis
|
GO:0003203 |
18 |
0.042
|
|
|
|
negative regulation of hormone secretion
|
GO:0046888 |
20 |
0.042
|
|
|
|
positive regulation of axon extension
|
GO:0045773 |
20 |
0.042
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.042
|
|
|
|
retinal ganglion cell axon guidance
|
GO:0031290 |
18 |
0.041
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.041
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.041
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.041
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.041
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.041
|
Mouse |
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.041
|
|
|
|
regulation of muscle adaptation
|
GO:0043502 |
31 |
0.041
|
|
|
|
negative regulation of blood pressure
|
GO:0045776 |
22 |
0.041
|
|
|
|
positive regulation of alpha beta t cell differentiation
|
GO:0046638 |
28 |
0.040
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.040
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.040
|
|
|
|
myeloid dendritic cell activation
|
GO:0001773 |
25 |
0.040
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.040
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.040
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.040
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.040
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.039
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.039
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.039
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.039
|
|
|
|
regulation of lung blood pressure
|
GO:0014916 |
2 |
0.039
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.039
|
|
|
|
negative regulation of vasoconstriction
|
GO:0045906 |
2 |
0.039
|
|
|
|
osteoblast proliferation
|
GO:0033687 |
18 |
0.039
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
54 |
0.039
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.039
|
|
|
|
growth plate cartilage chondrocyte development
|
GO:0003431 |
3 |
0.038
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.038
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.038
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.038
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.038
|
Human |
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.038
|
|
|
|
mechanoreceptor differentiation
|
GO:0042490 |
67 |
0.038
|
|
|
|
notochord development
|
GO:0030903 |
20 |
0.038
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.037
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.037
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.037
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.037
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.037
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.037
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.037
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.036
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.036
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.036
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.036
|
Human |
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.035
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.035
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.035
|
|
|
|
filopodium assembly
|
GO:0046847 |
19 |
0.035
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.035
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.035
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.035
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.035
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.035
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.034
|
Human |
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.034
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.034
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902043 |
13 |
0.034
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.034
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.034
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.034
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.033
|
|
|
|
regulation of endothelial cell proliferation
|
GO:0001936 |
23 |
0.033
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.033
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.033
|
Human |
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.033
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.033
|
Human |
|
|
coagulation
|
GO:0050817 |
78 |
0.033
|
Human |
|
|
synapse organization
|
GO:0050808 |
125 |
0.033
|
|
|
|
synapse assembly
|
GO:0007416 |
56 |
0.033
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.033
|
Human |
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.033
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.032
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.032
|
|
|
|
regulation of serotonin uptake
|
GO:0051611 |
2 |
0.032
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.032
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.032
|
Human |
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.032
|
Human |
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.032
|
|
|
|
smad protein signal transduction
|
GO:0060395 |
21 |
0.032
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.032
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.032
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.032
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.032
|
Human |
|
|
superoxide metabolic process
|
GO:0006801 |
27 |
0.032
|
|
|
|
alpha amino acid catabolic process
|
GO:1901606 |
18 |
0.031
|
|
|
|
paraxial mesoderm morphogenesis
|
GO:0048340 |
10 |
0.031
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.031
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.031
|
Human |
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.031
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.031
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.031
|
Human |
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.031
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.031
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.031
|
Human |
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.031
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.030
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.030
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.030
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.030
|
Human |
|
|
regulation of alpha beta t cell differentiation
|
GO:0046637 |
35 |
0.030
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.030
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.030
|
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
34 |
0.030
|
|
|
|
growth plate cartilage development
|
GO:0003417 |
14 |
0.030
|
|
|
|
trachea formation
|
GO:0060440 |
3 |
0.029
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.029
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.029
|
Human |
|
|
physiological cardiac muscle hypertrophy
|
GO:0003301 |
3 |
0.029
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.029
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.029
|
|
|
|
endocardial cell differentiation
|
GO:0060956 |
4 |
0.029
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.029
|
Human |
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.029
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.029
|
|
|
|
retina vasculature development in camera type eye
|
GO:0061298 |
17 |
0.029
|
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
39 |
0.028
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.028
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.028
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.028
|
|
|
|
cgmp biosynthetic process
|
GO:0006182 |
13 |
0.028
|
|
|
|
positive regulation of tolerance induction
|
GO:0002645 |
8 |
0.028
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.028
|
|
|
|
cell aging
|
GO:0007569 |
35 |
0.028
|
|
|
|
striated muscle adaptation
|
GO:0014888 |
26 |
0.028
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.028
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.028
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.028
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.028
|
|
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.028
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.028
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.028
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.028
|
|
|
|
bronchus morphogenesis
|
GO:0060434 |
2 |
0.028
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.027
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.027
|
Human |
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.027
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.027
|
|
|
|
positive regulation of alpha beta t cell activation
|
GO:0046635 |
39 |
0.027
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.027
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.027
|
|
|
|
dorsal ventral axon guidance
|
GO:0033563 |
3 |
0.027
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.027
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.027
|
|
|
|
negative regulation of neurotransmitter uptake
|
GO:0051581 |
2 |
0.027
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.027
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.027
|
Human |
|
|
regulation of peptidyl threonine phosphorylation
|
GO:0010799 |
12 |
0.027
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.027
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.027
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.027
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.027
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.027
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.026
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.026
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.026
|
Human |
|
|
response to bmp
|
GO:0071772 |
14 |
0.026
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.026
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.026
|
|
|
|
g protein coupled receptor signaling pathway involved in heart process
|
GO:0086103 |
4 |
0.026
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.026
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.026
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.026
|
|
|
|
gastrulation with mouth forming second
|
GO:0001702 |
29 |
0.026
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.026
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.025
|
|
|
|
tolerance induction
|
GO:0002507 |
14 |
0.025
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.025
|
|
|
|
regulation of gastrulation
|
GO:0010470 |
16 |
0.025
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.025
|
|
|
|
regulation of pathway restricted smad protein phosphorylation
|
GO:0060393 |
6 |
0.025
|
|
|
|
negative regulation of systemic arterial blood pressure
|
GO:0003085 |
15 |
0.025
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.025
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.025
|
|
|
|
positive regulation of lymphocyte differentiation
|
GO:0045621 |
61 |
0.025
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.025
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.025
|
|
|
|
thymus development
|
GO:0048538 |
41 |
0.024
|
|
|
|
negative regulation of endothelial cell proliferation
|
GO:0001937 |
8 |
0.024
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.024
|
|
|
|
negative regulation of peptide secretion
|
GO:0002792 |
16 |
0.024
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.024
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.024
|
|
|
|
dna biosynthetic process
|
GO:0071897 |
22 |
0.024
|
|
|
|
maternal process involved in female pregnancy
|
GO:0060135 |
32 |
0.024
|
|
|
|
regulation of vasoconstriction
|
GO:0019229 |
14 |
0.024
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.024
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.024
|
Human |
|
|
fused antrum stage
|
GO:0048165 |
1 |
0.024
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.023
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.023
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.023
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.023
|
|
|
|
endochondral bone growth
|
GO:0003416 |
19 |
0.023
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.023
|
Human |
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.023
|
|
|
|
positive regulation of meiotic cell cycle
|
GO:0051446 |
15 |
0.023
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.023
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.023
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.023
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.023
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.023
|
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.023
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
33 |
0.023
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.023
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.023
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.023
|
|
|
|
maternal placenta development
|
GO:0001893 |
20 |
0.023
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.023
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.022
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.022
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.022
|
|
|
|
b cell tolerance induction
|
GO:0002514 |
2 |
0.022
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.022
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.022
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.022
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.022
|
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
37 |
0.022
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.022
|
|
|
|
lens fiber cell apoptotic process
|
GO:1990086 |
4 |
0.022
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.022
|
Human |
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.022
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.022
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.022
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.022
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.022
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.022
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.022
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.022
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.021
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.021
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.021
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.021
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.021
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.021
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.021
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.021
|
Human |
|
|
mesoderm structural organization
|
GO:0048338 |
1 |
0.021
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.021
|
Human |
|
|
gastrulation
|
GO:0007369 |
116 |
0.021
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.021
|
|
|
|
regulation of synapse assembly
|
GO:0051963 |
29 |
0.021
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.021
|
|
|
|
response to catecholamine
|
GO:0071869 |
4 |
0.021
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.021
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.021
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.021
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.021
|
|
|
|
regulation of mesoderm development
|
GO:2000380 |
12 |
0.021
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.021
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.021
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.020
|
Human |
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.020
|
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.020
|
|
|
|
regulation of peptidyl lysine acetylation
|
GO:2000756 |
22 |
0.020
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.020
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.020
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.020
|
|
|
|
cardiac muscle tissue growth
|
GO:0055017 |
37 |
0.020
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.020
|
|